Phoenix in the Future: Unveiling the Product Roadmap and the New TFL Module [APAC Webinar] On-Demand Webinar Phoenix in the Future: Unveiling the Product Roadmap and the New TFL Module [APAC Webinar] Principal Research Scientist Dr. Kristin Follman is a Principal Research Scientist at Certara, where she…CertaraJanuary 15, 2025
EMWA Spring Conference Conference EMWA Spring Conference May 6-9, 2025 - Riga, LatviaCertaraJanuary 15, 2025
Achieve Clinical Data Transparency with the 4 Cs of Collaboration Blog Achieve Clinical Data Transparency with the 4 Cs of Collaboration In this blog, we look at how you can enhance clinical data transparency and make…CertaraJanuary 15, 2025
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region Publication Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region The integration of MID3 offers a transformative opportunity for the MENA region to advance pharmaceutical…CertaraJanuary 14, 2025
What 2025 could bring for psychedelic use in healthcare Press Coverage What 2025 could bring for psychedelic use in healthcare Explore the evolving landscape of psychedelic medicine, featuring updates from key players and insights on…CertaraJanuary 13, 2025
Simcyp® In Vitro Data Analysis (SIVA) Toolkit Fact Sheet Simcyp® In Vitro Data Analysis (SIVA) Toolkit CertaraJanuary 10, 2025
Unlock Global Regulatory Success: Overcoming Early Drug Development Challenges [APAC Webinar] On-Demand Webinar Unlock Global Regulatory Success: Overcoming Early Drug Development Challenges [APAC Webinar] Navigating early drug development is critical to ensuring the long-term success of therapeutic candidates. This…CertaraJanuary 10, 2025
Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters Blog Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters January 10, 2025 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A…CertaraJanuary 10, 2025
Certara Appoints New Head of Biometrics, Data Science, and Access Announcement Certara Appoints New Head of Biometrics, Data Science, and Access January 10, 2025 RADNOR, PA. – January 10, 2025 – Certara, Inc. (Nasdaq: CERT), a global…CertaraJanuary 10, 2025
Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) On-Demand Webinar Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive…CertaraJanuary 9, 2025